Search Within

Kaitlyn Gill

Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
  3. Editorial (1)
Groups
  1. Department of Medicine (6)
  2. Department of Pathology and Laboratory Medicine (6)
  3. GDMT, Pathology and Laboratory Medicine (6)
  4. Graduate Medical Education (6)
  5. Gynecology Disease Management Team (6)
  6. Sloan Kettering Institute Postdocs (6)

More Groups

People
  1. Britta Weigelt (6)
  2. David Brown (5)
  3. Hunter Green (5)
  4. Arnaud Da Cruz Paula (4)
  5. Jose Dopeso Gonzalez (4)
  6. Michael Herman Chui (4)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2019 (1)
Publications
  1. Gynecologic Oncology (4)
  2. Cancer Research (1)
  3. International Journal of Gynecological Pathology (1)
  4. Journal of Clinical Oncology (1)
Publishers
  1. Elsevier Inc. (4)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. Lippincott Williams & Wilkins (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TROP2 expression and therapeutic targeting in uterine carcinosarcoma
    Journal Article

    Moufarrij, S.; Dopeso, H.; Brown, D. N.; Green, H.; Gill, K.; Tengelin, J.; Brodeur, M. N.; Zammarrelli, W. A. 3rd; Varice, N.; Wu, M.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Intraperitoneal therapy with engineered Newcastle disease virus encoding interleukin-12 in combination with PD-1 blockade for ovarian cancer
    Meeting Abstract

    Kahn, R.; Ozsoy, M. A.; Green, H.; Gill, K.; Praiss, A.; Pesci, G.; Burman, B.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • TROP2 as a novel target in uterine carcinosarcoma organoid models
    Meeting Abstract

    Moufarrij, S.; Dopeso, H.; Green, H.; Gill, K.; Brown, D.; Zammarrelli, W.; Varice, N.; Wu, M.; Paula, A. D.; de Oliveira, T. B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Sensitivity of HER2-low uterine carcinosarcoma organoids to the antibody-drug conjugate, trastuzumab deruxtecan
    Meeting Abstract

    Moufarrij, S.; Dopeso, H.; Green, H.; Gill, K.; Brown, D.; Zammarrelli, W.; Varice, N.; Wu, M.; Paula, A. D.; de Oliveira, T. B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A genomics-driven artificial intelligence–based model classifies breast invasive lobular carcinoma and discovers CDH1 inactivating mechanisms
    Journal Article

    Pareja, F.; Dopeso, H.; Wang, Y. K.; Gazzo, A. M.; Brown, D. N.; Banerjee, M.; Selenica, P.; Bernhard, J. H.; Derakhshan, F.; da Silva, E. M.; more...
    Cancer Research (2024)

    Fulltext@MSK | Save
  • High-risk human papillomavirus-associated mixed intestinal-type mucinous adenocarcinoma and low-grade neuroendocrine tumor of the uterine cervix: report of a case harboring shared ARID1A and SMAD4 mutations between morphologically distinct components
    Editorial

    Alwaqfi, R.; Gill, K.; Brown, D. N.; Weigelt, B.; Park, K. J.; Chui, M. H.
    International Journal of Gynecological Pathology (2024)

    Fulltext@MSK | Save
  • A large retrospective analysis of CDK 4/6 inhibitor retreatment in ER+ metastatic breast cancer (MBC)
    Meeting Abstract

    dos Anjos, C. H.; Razavi, P.; Herbert, J.; Colon, J.; Gill, K.; Modi, S.; Bromberg, J.; Dang, C. T.; Liu, D.; Norton, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save